NYSE:ATRPackaging
Will MGH Research Tie Up Change Aptar Stock Narrative
AptarGroup announced a research collaboration with Massachusetts General Hospital, led by Alice Stanton, PhD, to build a translational platform for nose-to-brain drug delivery using in vitro, in vivo and computational tools that integrate the company’s nasal systems such as Cerespray and Neurospray.
The work aims to create New Approach Methodologies consistent with FDA support. These methodologies could help pharmaceutical partners screen CNS candidates more efficiently, refine formulations...